Who is moving to which position
Resolved 5 November 2026Incoming appointee
1 itemDeparting officer
1 item“Next role stated” means the document names the position the person holds after stepping down. It does not necessarily mean they are leaving the company.
Continuing in office (remaining on the Board of Directors as Representative Director and Chairman)
Current Senior Executive Officer Murano Tadayuki (村野忠之) will become President Executive Officer and CEO, overseeing the company's overall management, on 1 January 2027, and will become a Representative Director in March of the same year. Current Representative Director, President Executive Officer and CEO Hirai Yoshinori (平井良典) will become Representative Director and Chairman on 1 January 2027.
| Item | Details |
|---|---|
| Resolution date | 5 November 2026 |
| Scheduled Appointment Date | 30 March 2027 (appointment as Representative Director, President Executive Officer and CEO; scheduled to become President Executive Officer and CEO on 1 January 2027) |
| Date of departure | 30 March 2027 |
| Name of appointee | Murano Tadayuki (村野忠之) |
| Appointee's new position | Representative Director, President Executive Officer and CEO |
| Appointee's previous position | Senior Executive Officer and President of the Life Science Company |
| Appointee's date of birth | 8 July 1965 |
| Year the appointee joined the Company | 1989 |
| Number of shares held by the appointee | 10,400 shares (record date: not disclosed) |
| Name of departing officer | Hirai Yoshinori (平井良典) |
| Former position of departing officer | Representative Director, President Executive Officer and CEO |
| New position of departing officer | Representative Director and Chairman |
| Whether the incumbent will remain in office | Continuing in office (remaining on the Board of Directors as Representative Director and Chairman) |
| Reason for change | Current Senior Executive Officer Murano Tadayuki (村野忠之) will become President Executive Officer and CEO, overseeing the company's overall management, on 1 January 2027, and will become a Representative Director in March of the same year. Current Representative Director, President Executive Officer and CEO Hirai Yoshinori (平井良典) will become Representative Director and Chairman on 1 January 2027. |
| Subject to Approval by the General Meeting of Shareholders | Required. Formal appointment is scheduled to take place following approval at the Ordinary General Meeting of Shareholders scheduled for late March 2027 and a subsequent resolution of the Board of Directors. |
Items this document does not state (6)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The transition to a management structure with Murano Tadayuki (村野忠之) as President Executive Officer and CEO and Hirai Yoshinori (平井良典) as Representative Director and Chairman. The appointments have been informally decided based on the recommendation of the Nomination Committee and a resolution of the Board of Directors.